PERSPECTA

News from every angle

← Back to headlines

Hims & Hers Faces Challenges to 2026 Guidance Amid Wegovy Risk

Bank of America analysts suggest Hims & Hers faces a significant challenge to meet its 2026 financial guidance, citing potential churn risk related to the weight-loss drug Wegovy.

26 May, 18:54 — 26 May, 18:54
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual3d ago

Hims & Hers faces steep climb to hit 2026 guidance as Wegovy churn risk looms, says BofA

Read full article →

Related Stories

Amazon's First Customer Receipt Goes Viral, Bezos and Musk React

just now

Metro Cebu Water District and Manila Water Expand Water Access in Compostela

just now

Business Leaders Discuss Jerusalem's Hi-Tech Future

just now

IMF and IEA Warn of Summer Fuel Shortages

7m ago